Gram-negative bacteremia upon hospital admission: when should Pseudomonas aeruginosa be suspected?

Vered Schechner1, Vandack Nobre, Keith S Kaye

  • 1Division of Epidemiology, Sourasky Medical Center, Tel Aviv, Israel. vereds@tasmc.health.gov.il

Abstract

Insights

Pseudomonas aeruginosa bacteremia is rare in hospitalized patients without severe immunodeficiency. Clinicians should consider empirical anti-pseudomonal treatment if 2 or more risk factors are present.

Area of Science:

  • Infectious Diseases
  • Clinical Microbiology
  • Epidemiology

Background:

  • Pseudomonas aeruginosa is an infrequent cause of community-acquired bacteremia, particularly in non-immunocompromised individuals.
  • Clinical decisions regarding empirical anti-pseudomonal therapy are challenging due to the need to balance judicious antibiotic use with timely treatment.
  • There is a need for improved guidance to identify patients at risk for P. aeruginosa bacteremia upon hospital admission.

Purpose of the Study:

  • To determine the incidence of P. aeruginosa bacteremia at hospital admission.
  • To develop a predictive model for identifying patients with P. aeruginosa bacteremia.

Main Methods:

  • A retrospective study was conducted across four tertiary care hospitals.
  • Microbiology databases were searched for Gram-negative rod (GNR) bacteremia within 48 hours of admission.
  • Logistic regression analysis identified independent predictors of P. aeruginosa bacteremia.

Main Results:

  • P. aeruginosa accounted for 6.8% of GNR bacteremia episodes at admission (5 cases per 10,000 admissions).
  • Independent predictors included severe immunodeficiency, age >90 years, recent antimicrobial therapy, and presence of central venous or urinary devices.
  • In patients without severe immunodeficiency, the risk of P. aeruginosa bacteremia increased from 1:42 to nearly 1:3 with two or more predictors.

Conclusions:

  • P. aeruginosa bacteremia at hospital admission is uncommon in patients without severe immunodeficiency.
  • Empirical anti-pseudomonal treatment is recommended for immunocompetent patients with suspected GNR bacteremia and two or more identified predictors.

Related Concept Videos

Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include: